The Correlation Between Pre-Treatment Inflammatory Markers and the Treatment of Breast Cancer

Name: The Correlation Between Pre-Treatment Inflammatory Markers and the Treatment of Breast Cancer
Brand: Eliva Press
Availability: OutOfStock
Rating: 5 (1 reviews)

By Jiaju Xu

0 - Default Title

Description

There is increasing evidence demonstrating that systemic inflammation is critically involved in promoting tumor progression and metastasis. Inflammatory markers, including neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) or lymphocyte/monocyte ratio (LMR) may partially reflect the immune function in the body. Numerous researches have shown that increased NLR, PLR and LMR are associated with poor prognosis in BC.The predictive significance of pre-treatment NLR / PLR / LMR for and neoadjuvant therapy (NAC) efficacyis not fully understood, and the results were controversial. Herein, this study was designed to assess the correlation of pre-treatment NLR, PLR and LMR with menopausal status and Ki67 LI, and to determine whether they were predictive factors for NAC responses.
This is the first case report describing a patient with non-small cell lung cancer (NSCLC) harboring two rare human epidermal growth factor receptor 2 (HER2) exon 21 insertion mutations, who responded to furmonertinib treatment.

Product details

Binding:: Paperback
Number of Pages:: 68
Release Date:: 2024-11-14
Publication Date:: 2024-09-11
Publisher:: Eliva Press
Languages:: Original: English
ISBN10:: 9999321623
ISBN13:: 9789999321624
Weight:: 114 g
Height:: 152 cm
Width:: 229 cm
Thickness:: 4 cm

Buy on Amazon

Currently sold out

Add to Wishlist